Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2009
04/02/2009CA2699068A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699065A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699055A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699054A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699052A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699049A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699047A1 Use of a peptide as a therapeutic agent
04/02/2009CA2699039A1 Use of bpp-b as a therapeutic agent
04/02/2009CA2699035A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
04/02/2009CA2699000A1 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-arg-gly-asp-asn-pro-oh as a therapeutic agent
04/02/2009CA2698775A1 Big gastrin i as a therapeutic agent
04/02/2009CA2698772A1 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent
04/02/2009CA2698768A1 Use of a peptide as a therapeutic agent
04/02/2009CA2698764A1 Use of a peptide as a therapeutic agent
04/02/2009CA2698762A1 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
04/02/2009CA2698751A1 Use of a peptide as a therapeutic agent
04/02/2009CA2698673A1 Use of a peptide as a therapeutic agent
04/02/2009CA2698672A1 Use of a peptide as a therapeutic agent
04/01/2009EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA)
04/01/2009EP2042503A1 Compound having acidic group which may be protected, and use thereof
04/01/2009EP2042499A1 Salt of morpholine compound
04/01/2009EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists
04/01/2009EP2042181A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
04/01/2009EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases
04/01/2009EP2041168A2 Novel analogs of vasoactive intestinal peptide
04/01/2009EP2041135A1 8-oxoadenine derivatives acting as modulators of tlr7
04/01/2009EP2040721A1 Medicinal compositions containing honey
04/01/2009EP2040714A2 Method for the eradication of pathogens comprising generating molecular iodine in situ
04/01/2009EP2040707A2 Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
04/01/2009EP1660431B1 Phenoxyacetic acid derivatives
04/01/2009EP1473295B1 Fused bicyclic pyrimidine derivatives
04/01/2009EP1137666B9 Glp-1 analogues
04/01/2009CN101400356A Treatment of acute respiratory distress syndrome
04/01/2009CN101396558A Medicinal preparation for treating rhinitis and sinusitis
04/01/2009CN101396546A Preparation method of kudzu root decoction
04/01/2009CN101396544A Traditional Chinese medicine composition capable of ventilating the lung and relieving asthma and preparation and quality control method thereof
04/01/2009CN101396536A Traditional Chinese medicine oral liquid for treating livestock and poultry respiratory disease
04/01/2009CN101396535A Traditional Chinese medicine oral liquid for treating livestock and poultry respiratory disease
04/01/2009CN101396528A Traditional Chinese medicine composite preparation for treating wind-heat cold
04/01/2009CN101396524A Oral preparation for treating chronic bronchitis
04/01/2009CN101396523A Medicine for treating chronic pharyngitis and preparation method thereof
04/01/2009CN101396522A Medicine for treating pharyngitis
04/01/2009CN101396488A Medicine for treating chronic faucitis
04/01/2009CN101396486A Traditional Chinese medicine composition for treating cough and asthma and preparation and quality control method thereof
04/01/2009CN101396466A Cold medicine tea composition as medicine and food, preparation method and use thereof
04/01/2009CN101396465A Traditional Chinese medicine for treating chronic suppurative tonsillitis
04/01/2009CN101396452A Cold prevention medicine
04/01/2009CN101396438A Traditional Chinese medicine oral liquid capable of relieving cough and asthma and use thereof in livestock and poultry
04/01/2009CN101396431A Bitongning gel and its preparing method
04/01/2009CN101396425A Preparation method of ballon-flower decoction
04/01/2009CN101396420A Extraction method of traditional Chinese medicine with antibiotic effect and use thereof in livestock and poultry
04/01/2009CN101396389A Senecio cannabifolius effective constituent extraction method and preparation method of granules thereof
04/01/2009CN101396382A Composite isatis root orally disintegrating tablet and preparation method thereof
04/01/2009CN101396370A Medicine composition for treating mouth, throat disease and preparation method thereof
04/01/2009CN101396368A Use of iso-glycyrrhizic acid and salt thereof in treating allergic rhinitis
04/01/2009CN101396365A Uses of 2-[piperidinyl] methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one
04/01/2009CN101396359A Use of alkaloids compound in preparing medicine for treating cough
04/01/2009CN100473987C Quality control method for Chinese medicine composition preparation for treating children's cold
04/01/2009CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response
04/01/2009CN100473408C Heat-clearing and phlegm-resolving medicine composition, preparation and use thereof
04/01/2009CN100473407C Chinese medical preparation for curing common cold and cough and preparation method thereof
04/01/2009CN100473398C Chinese medicine preparation for treating respiratory tract infection and virus flu, preparing method thereof
04/01/2009CN100473394C Compound preparation of baikal skullcap root
03/2009
03/31/2009US7511159 Azetidine ring compounds and drugs comprising the same
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/31/2009US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders
03/31/2009US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors
03/31/2009US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/31/2009US7511061 Triazoles as farnesyl transferase inhibitors
03/31/2009US7511047 Kinase inhibitors
03/31/2009US7511024 Factor VII or VIIA-like molecules
03/31/2009US7511011 Synthetic lipid mixtures for the preparation of a reconstituted surfactant
03/31/2009US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders
03/31/2009CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
03/31/2009CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/31/2009CA2349268C A process for the preparation of suspensions of drug particles for inhalation delivery
03/31/2009CA2328368C Anti-inflammatory agents
03/31/2009CA2066204C Cystic fibrosis gene
03/26/2009WO2009039310A2 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
03/26/2009WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient
03/26/2009WO2009038157A1 2,3-dihydroiminoisoindole derivative
03/26/2009WO2009037584A2 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
03/26/2009WO2009037468A1 Thienopyrimidine compounds and compositions
03/26/2009WO2009037463A1 Thienopyrimidine compounds
03/26/2009WO2009037413A1 Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases
03/26/2009WO2009037111A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
03/26/2009WO2008145688A3 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
03/26/2009WO2008137780A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
03/26/2009WO2008058897A3 Diphyllin and other lignans as a medicament for v-atpase mediated disease
03/26/2009WO2008058269A3 Compounds and methods for modulating protein trafficking
03/26/2009WO2008005194A4 Method for the eradication of pathogens comprising generating molecular iodine in situ
03/26/2009WO2005044802A3 Tetrahydro-quinolinylurea derivatives as vrl antagonists
03/26/2009US20090082567 2,4-pyrimidinediamine compounds and their uses
03/26/2009US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin
03/26/2009US20090082468 Deuterium-enriched levalbuterol
03/26/2009US20090082433 Preventative treatment and remission of allergic diseases
03/26/2009US20090082416 Deuterium-enriched bendamustine
03/26/2009US20090082390 Piperidine compounds for use as orexin receptor antagonist
03/26/2009US20090082387 Deuterium-enriched nvp-bez234
03/26/2009US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use